Quantcast

Latest Thalidomide Stories

2009-02-01 13:47:43

Thalidomide victims in Britain say the government is denying them financial aid as they age and their health worsens. It's estimated more than 450 people whose mothers took thalidomide during pregnancy are nearing 50 and suffering physical breakdowns, The Sunday Times of London reported. Thousands of British mothers were prescribed thalidomide as a cure for morning sickness, and gave birth to babies who then died or grew up with drastically stunted arms and fingers and no shoulder joints....

2008-12-09 09:00:00

SOUTH SAN FRANCISCO, Calif., Dec. 9 /PRNewswire/ -- Proteolix, Inc. today announced positive clinical data demonstrating that the company's lead product, carfilzomib, has single-agent activity and promotes durable responses in patients with relapsed and refractory multiple myeloma.

2008-11-06 15:00:28

The International Myeloma Foundation (IMF)--supporting research and providing education, advocacy and support for myeloma patients, families, researchers and physicians--today called for all patients to have access to the newest pharmaceuticals making life-changing advances in the treatment of myeloma.

2008-10-30 09:00:40

Revlimid has become the latest in a series of oncology drugs that have failed to satisfy NICE's cost-effectiveness criteria. As a result, Celgene's drug will not be available to multiple myeloma patients on the UK's National Health Service.

2008-10-17 09:00:27

Celgene and Acceleron Pharma have initiated a Phase II clinical study of its lead compound ACE-011 in patients with multiple myeloma. Celgene will make a $5 million milestone payment to Acceleron in accordance with the terms of the collaboration agreement between the two companies.

2008-10-16 09:00:10

Celgene Corporation (NASDAQ:CELG) and Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced the initiation of a Phase 2 clinical study of its lead compound ACE-011 in patients with multiple myeloma.

2008-10-06 12:00:42

Celgene International, a wholly owned subsidiary of Celgene Corporation, has announced that its oral cancer drug Revlimid has received marketing authorization approval from Health Canada for use in combination with dexamethasone as a treatment for patients with multiple myeloma who have received at least one prior therapy.

2008-10-03 18:00:32

Tokyo, Oct. 3 (Jiji Press)--A Japanese Health, Labor and Welfare Ministry panel on Friday approved the production and sale of thalidomide, a controversial sedative-hypnotic banned more than 40 years ago, for the treatment of multiple myeloma, a type of blood cancer, under strict conditions.


Word of the Day
dapifer
  • One who brings meat to the table; hence, in some countries, the official title of the grand master or steward of the king's or a nobleman's household.
The word 'dapifer' comes from Latin roots meaning 'feast' and 'bearer'.